[go: up one dir, main page]

TW200730480A - Organic compounds - Google Patents

Organic compounds

Info

Publication number
TW200730480A
TW200730480A TW095135800A TW95135800A TW200730480A TW 200730480 A TW200730480 A TW 200730480A TW 095135800 A TW095135800 A TW 095135800A TW 95135800 A TW95135800 A TW 95135800A TW 200730480 A TW200730480 A TW 200730480A
Authority
TW
Taiwan
Prior art keywords
organic compounds
compound
novel
formula
novel process
Prior art date
Application number
TW095135800A
Other languages
English (en)
Inventor
Stuart John Mickel
Wolfgang Marterer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200730480(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200730480A publication Critical patent/TW200730480A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
TW095135800A 2005-09-28 2006-09-27 Organic compounds TW200730480A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds

Publications (1)

Publication Number Publication Date
TW200730480A true TW200730480A (en) 2007-08-16

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095135800A TW200730480A (en) 2005-09-28 2006-09-27 Organic compounds

Country Status (27)

Country Link
US (2) US7973175B2 (zh)
EP (2) EP2287153A1 (zh)
JP (1) JP2009509990A (zh)
KR (1) KR20080048042A (zh)
CN (1) CN101273012A (zh)
AR (1) AR057137A1 (zh)
AT (1) ATE492533T1 (zh)
AU (1) AU2006299097B2 (zh)
BR (1) BRPI0616707A2 (zh)
CA (1) CA2623495A1 (zh)
DE (1) DE602006019114D1 (zh)
EC (1) ECSP088319A (zh)
ES (1) ES2358536T3 (zh)
GB (1) GB0519764D0 (zh)
GT (1) GT200600427A (zh)
IL (1) IL189763A0 (zh)
MA (1) MA29852B1 (zh)
MY (1) MY143251A (zh)
NO (1) NO20082005L (zh)
NZ (1) NZ566429A (zh)
PE (1) PE20070488A1 (zh)
PL (1) PL1931629T3 (zh)
PT (1) PT1931629E (zh)
RU (1) RU2423348C2 (zh)
TN (1) TNSN08142A1 (zh)
TW (1) TW200730480A (zh)
WO (1) WO2007039183A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
EP2189442B1 (en) 2008-11-20 2014-10-01 Krka Tovarna Zdravil, D.D., Novo Mesto Process and intermediates for the preparation of aliskiren
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
CN101774986B (zh) * 2010-01-06 2012-03-28 浙江天宇药业股份有限公司 一种制备阿利克伦及其中间体的方法
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
HU228526B1 (hu) 2000-07-05 2013-03-28 Speedel Pharma Ag Eljárás szubsztituált oktanoil-amid-származékok elõállítására, valamint az elõállításhoz alkalmazott közbensõ termékek
DE10116816A1 (de) 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AU2006299097A1 (en) 2007-04-12
ECSP088319A (es) 2008-04-28
JP2009509990A (ja) 2009-03-12
ES2358536T3 (es) 2011-05-11
AR057137A1 (es) 2007-11-21
MY143251A (en) 2011-04-15
RU2008116317A (ru) 2009-11-10
EP1931629B1 (en) 2010-12-22
GB0519764D0 (en) 2005-11-09
PE20070488A1 (es) 2007-06-13
GT200600427A (es) 2007-04-30
NO20082005L (no) 2008-06-24
MA29852B1 (fr) 2008-10-03
BRPI0616707A2 (pt) 2011-06-28
CN101273012A (zh) 2008-09-24
US20110230665A1 (en) 2011-09-22
WO2007039183A1 (en) 2007-04-12
AU2006299097B2 (en) 2010-11-04
US7973175B2 (en) 2011-07-05
NZ566429A (en) 2010-10-29
EP2287153A1 (en) 2011-02-23
US20080255369A1 (en) 2008-10-16
PL1931629T3 (pl) 2011-05-31
DE602006019114D1 (de) 2011-02-03
CA2623495A1 (en) 2007-04-12
IL189763A0 (en) 2008-08-07
PT1931629E (pt) 2011-03-09
TNSN08142A1 (en) 2009-07-14
RU2423348C2 (ru) 2011-07-10
ATE492533T1 (de) 2011-01-15
KR20080048042A (ko) 2008-05-30
EP1931629A1 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
TNSN08170A1 (en) 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
TN2009000401A1 (en) New methods
WO2011015522A3 (en) Process for the manufacture of pharmaceutically active compounds
TNSN07465A1 (en) Organic compounds
GB0719180D0 (en) New process
WO2008155338A3 (en) Process for the synthesis of intermediates of renin inhibitors such as aliskiren
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
IL190551A0 (en) Novel process for the preparation of acid chlorides
WO2008096231A8 (en) Antiparasitic agents
TW200613274A (en) Organic compounds
TNSN08142A1 (en) Synthesis of renin inhibitors involving a cycloaddition reaction
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
TW200609215A (en) Organic compounds
TW200702330A (en) 3,4,5-Substituted piperidines
WO2005085236A3 (en) Caspase inhibitors and uses thereof
MY143324A (en) Process for preparing phosphorus compounds having phosphate-phosphonate bond
WO2006136552A3 (en) Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
WO2007044490A3 (en) Process for making heteroaryl amine intermediate compounds
TH88107A (th) สารประกอบอินทรีย์
WO2010004269A3 (en) Stereospecific synthesis of iduronic acid derivatives, deoxynojirimycin and deoxyidonojirimycin
WO2004069790A3 (en) Crystalline modifications of triazinylaminostilbenes
TH89325A (th) อนุพันธ์ของ 3-อัลคิล-5-(4-อัลคิล-5-ออกโซ-เตตระไฮโดรฟิวราน-2-อิล)ไพรโรลิดิน-2-โอน (3-alkyl-5-(4-alkyl-5-oxo-tetrahydrifuran-2-yl)pyrrolidin-2-one) ในฐานะเป็นสารมัธยันต์ในการสังเคราะห์ของสารยับยั้งเรนิน